{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:49:20Z","timestamp":1792813760636,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ijrobp.2022.03.027","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T11:38:16Z","timestamp":1648813096000},"page":"796-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Efficacy and Safety of Apatinib for Radiation-induced Brain Injury Among Patients With Head and Neck Cancer: An Open-Label, Single-Arm, Phase 2 Study"],"prefix":"10.1016","volume":"113","author":[{"given":"Lei","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxuan","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingru","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongwei","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin Lee Kiang","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Lattanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gaertner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3517-8103","authenticated-orcid":false,"given":"Yamei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.03.027_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ajco.12124","article-title":"Cerebral radiation necrosis","volume":"10","author":"Na","year":"2014","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0002","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/0360-3016(94)00550-8","article-title":"Neuropsychological effects of cranial radiation: Current knowledge and future directions","volume":"31","author":"Roman","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-8-88","article-title":"Neurosurgery and prognosis in patients with radiation-induced brain injury after nasopharyngeal carcinoma radiotherapy: A follow-up study","volume":"8","author":"Li","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0004","doi-asserted-by":"crossref","first-page":"e1392","DOI":"10.1212\/WNL.0000000000010190","article-title":"A nomogram to predict symptomatic epilepsy in patients with radiation-induced brain necrosis","volume":"95","author":"Huang","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.radonc.2018.11.008","article-title":"A nomogram for the prediction of cerebrovascular disease among patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma","volume":"132","author":"Cai","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0006","doi-asserted-by":"crossref","unstructured":"Yang Z, Bai S, Gu B, Peng S, Liao W, Liu J. Radiation-induced brain injury after radiotherapy for brain tumor. In: Molecular Considerations and Evolving Surgical Management Issues in the Treatment of Patients with a Brain Tumor. London: IntechOpen; 2015. Available at: https:\/\/www.intechopen.com\/chapters\/47566. Accessed June 19, 2022.","DOI":"10.5772\/59045"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0007","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00066-010-2184-4","article-title":"Bevacizumab as a treatment option for radiation-induced cerebral necrosis","volume":"187","author":"Matuschek","year":"2011","journal-title":"Strahlentherapie und Onkol Case"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0008","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijrobp.2018.04.068","article-title":"Bevacizumab monotherapy reduces radiation-induced brain necrosis in nasopharyngeal carcinoma patients: A randomized controlled trial","volume":"101","author":"Xu","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"46","key":"10.1016\/j.ijrobp.2022.03.027_bib0009","first-page":"1","article-title":"Apatinib in refractory radiation-induced brain edema: A case report","volume":"96","author":"Hu","year":"2017","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.14740\/jocmr2936e","article-title":"Bevacizumab for the treatment of radiation-induced cerebral necrosis: A systematic review of the literature","volume":"9","author":"Delishaj","year":"2017","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0011","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6004\/jnccn.2008.0039","article-title":"Antiangiogenesis treatment for glioblastoma multiforme: Challenges and opportunities","volume":"6","author":"Wong","year":"2008","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0012","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3346\/jkms.2004.19.6.879","article-title":"Upregulation of VEGF and FGF2 in normal rat brain after experimental intraoperative radiation therapy","volume":"19","author":"Kim","year":"2004","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0013","first-page":"3348","article-title":"Hypoxia in radiation-induced blood-spinal cord barrier breakdown","volume":"61","author":"Li","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0014","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2006.10.010","article-title":"Effect of bevacizumab on radiation necrosis of the brain","volume":"67","author":"Gonzalez","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/35025215","article-title":"Vascular-specific growth factors and blood vessel formation","volume":"407","author":"Yancopoulos","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0016","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijrobp.2010.11.070","article-title":"Clinical outcomes of 174 nasopharyngeal carcinoma patients with radiation-induced temporal lobe necrosis","volume":"82","author":"Lam","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0017","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/neuonc\/not085","article-title":"Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery","volume":"15","author":"Boothe","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0018","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","article-title":"Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system","volume":"79","author":"Levin","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0019","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11060-014-1391-8","article-title":"An analysis of radiation necrosis of the central nervous system treated with bevacizumab","volume":"117","author":"Tye","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0020","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1158\/1078-0432.CCR-20-1264","article-title":"A radiomics model for predicting the response to bevacizumab in brain necrosis after radiotherapy","volume":"26","author":"Cai","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0021","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ijrobp.2017.11.023","article-title":"Clinical variables for prediction of the therapeutic effects of bevacizumab monotherapy in nasopharyngeal carcinoma patients with radiation-induced brain necrosis","volume":"100","author":"Li","year":"2017","journal-title":"Radiat Oncol Biol"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0022","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S1470-2045(18)30349-8","article-title":"Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): A phase 2, single-arm, prospective study","volume":"19","author":"Lan","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0023","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1186\/1471-2407-14-820","article-title":"Multicenter phase II study of apatinib in non-triple-negative metastatic breast cancer","volume":"14","author":"Hu","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0024","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/15384047.2018.1491502","article-title":"Successful treatment using apatinib in intractable brain edema: A case report and literatures review","volume":"19","author":"Song","year":"2018","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0025","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","article-title":"User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability","volume":"313","author":"Yushkevich","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0026","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0360-3016(02)04578-9","article-title":"Evaluation of the LENT-SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma","volume":"56","author":"Routledge","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0027","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11060-014-1573-4","article-title":"Effect of edaravone on radiation-induced brain necrosis in patients with nasopharyngeal carcinoma after radiotherapy: A randomized controlled trial","volume":"120","author":"Tang","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0028","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.radonc.2019.04.015","article-title":"Comparison between high-dose and low-dose intravenous methylprednisolone therapy in patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma","volume":"137","author":"Zhuo","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0029","first-page":"373","article-title":"The management of brain necrosis as a result of SRS treatment for intra-cranial tumor","volume":"3","author":"Patel","year":"2014","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1537-1891(03)00011-9","article-title":"Regulation of vascular permeability by vascular endothelial growth factors","volume":"39","author":"Bates","year":"2002","journal-title":"Vascul Pharmacol"},{"issue":"7","key":"10.1016\/j.ijrobp.2022.03.027_bib0031","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006502","article-title":"Signal transduction by vascular endothelial growth factor receptors","volume":"2","author":"Koch","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0032","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0033","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1200\/JCO.2015.63.5995","article-title":"Randomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction","volume":"34","author":"Li","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0034","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1634\/theoncologist.12-4-443","article-title":"Target practice: Lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer","volume":"12","author":"Los","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0035","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1200\/JCO.2013.48.8585","article-title":"Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: Results from a randomized, placebo-controlled, parallel-arm, phase II trial","volume":"31","author":"Li","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0036","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1158\/1078-0432.CCR-20-2571","article-title":"Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A nonrandomized, open-label, phase II trial","volume":"27","author":"Xu","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2022.03.027_bib0037","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jtho.2020.10.002","article-title":"Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A multicenter, two-stage, phase 2 trial","volume":"16","author":"Fan","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"suppl 15","key":"10.1016\/j.ijrobp.2022.03.027_bib0038","article-title":"Camrelizumab plus apatinib in patients with advanced cervical cancer: A multicenter, open-label, single-arm, phase II trial","volume":"38","author":"Lan","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622002681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622002681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:01:57Z","timestamp":1759744917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622002681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0360301622002681"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.03.027","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Apatinib for Radiation-induced Brain Injury Among Patients With Head and Neck Cancer: An Open-Label, Single-Arm, Phase 2 Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}